UBS Group AG - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 14 filers reported holding MONOPAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45
-99.5%
72
-98.9%
0.00%
Q1 2023$8,879
+18.8%
6,388
+102.5%
0.00%
Q4 2022$7,475
-6.6%
3,154
-41.6%
0.00%
Q3 2022$8,000
-82.2%
5,399
-72.4%
0.00%
Q2 2022$45,000
+462.5%
19,561
+529.8%
0.00%
Q1 2022$8,000
-20.0%
3,106
+1.3%
0.00%
Q4 2021$10,000
+150.0%
3,067
+437.1%
0.00%
Q1 2021$4,000
-33.3%
571
-40.0%
0.00%
Q4 2020$6,000952
+6246.7%
0.00%
Q1 2020$0
-100.0%
15
-98.8%
0.00%
Q4 2019$21,0001,2900.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Windsor Advisory Group, LLC 89,974$55,7750.13%
Rappaport Reiches Capital Management, LLC 10,695$6,6300.00%
Tower Research Capital LLC (TRC) 3,727$2,3110.00%
JPMORGAN CHASE & CO 4$20.00%
VANGUARD GROUP INC 87,596$54,3010.00%
UBS Group AG 72$450.00%
WELLS FARGO & COMPANY/MN 33$200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 41,199$23,4830.00%
MILLENNIUM MANAGEMENT LLC 19,008$10,8350.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders